According to the preview, HCA expects income before income taxes to rise to $904 million for the second quarter of this year, compared with $806 million in 2013. Adjusted EBITDA for the quarter is expected to be approximately $2 billion, up 18 percent from $1.689 billion during the second quarter of 2013.
The financial results are still subject to finalization of the company’s quarterly and accounting procedures. HCA expects to report its complete financial results for the second quarter on or around July 29.
More Articles on HCA:
For-Profit Hospital Stock Report: Week of July 7-11, 2014
HCA’s Top Private Equity Owners to Sell 29.5M Shares
How Much 6 Major Hospital Operators Have Received in EHR Incentive Payments
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
